Insulet Aktie
248,90
EUR
+4,20
EUR
+1,72
%
263,12
USD
-0,19
USD
-0,07
%
Insulet Aktie Analyse
| 06.05.19 | Insulet Buy | BTIG Research | |
| 09.03.18 | Insulet Outperform | BMO Capital Markets | |
| 22.02.18 | Insulet overweight | Barclays Capital | |
| 03.11.17 | Insulet Buy | Canaccord Adams | |
| 15.09.17 | Insulet overweight | Barclays Capital | |
| 28.02.17 | Insulet Outperform | Wedbush Morgan Securities Inc. | |
| 06.01.17 | Insulet Outperform | Robert W. Baird & Co. Incorporated | |
| 26.02.16 | Insulet Buy | The Benchmark Company | |
|
Werbung
|
|||
| 06.11.15 | Insulet Outperform | Northland Capital | |
| 04.05.15 | Insulet Outperform | Northland Capital | |
| 01.05.15 | Insulet Buy | The Benchmark Company | |
| 16.01.15 | Insulet Outperform | Oppenheimer & Co. Inc. | |
| 12.11.14 | Insulet Outperform | Oppenheimer & Co. Inc. | |
| 13.08.12 | Insulet outperform | Barrington Research | |
| 14.05.12 | Insulet outperform | Barrington Research | |
| 14.02.12 | Insulet outperform | Barrington Research | |
| 07.05.10 | Insulet kaufen | Barrington Research | |